Commission rejects health claim on beta-glucans in ready-to-eat breakfast cereal
European Union
Jun 14, 2023
With Regulation (EU) 2023/1141 of 1 June 2023 the European Commission has rejected the request of authorization of a health claim related to beta-glucans sourced from oats and/or barley in ready-to-eat breakfast cereals manufactured via pressure cooking and to the reduction of blood glucose rise after consumption.
COMMISSION REGULATION (EU) 2023/1141 of 1 June 2023 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health:
Article 1
The health claims listed in the Annex to this Regulation shall not be included in the Union list of permitted health claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006.
ANNEX
Rejected health claims
Application – Relevant provisions of Regulation (EC) No 1924/2006 |
Nutrient, substance, food or food category |
Claim |
EFSA opinion reference |
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data |
Beta-glucans sourced from oats and/or barley, incorporated into ready-to-eat breakfast cereals manufactured via pressure cooking (i.e. either by batch cooking or extrusion), and present at a level of at least 1,3 g per 25 g available carbohydrate in the ready-to-eat cereal |
Consumption of beta-glucans from oats and/or barley in a ready-to-eat breakfast cereal contributes to a reduction of the blood glucose rise after that meal |
Q-2020-000447 |
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data |
Affron®, aqueous saffron extract, with the sum of crocins and safranal concentration > 3,5 % and dextrin as inert carrier |
Affron® contributes to maintain a healthy mood by reducing the negative traits of depressive and anxiety feelings |
Q-2020-00617 |
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data |
MegaNatural®-BP grape seed extract made entirely of California-grown grapes containing biologically active constituents: total phenolics (90–93 %), gallic acid (≥ 2 %) and catechin and epicatechin (≥ 5 %). The distribution of phenolic compounds in the MegaNatural®-BP is on average 9 % monomers, 69 % oligomers and 22 % polymers |
MegaNatural®-BP helps maintain healthy blood pressure |
Q-2020-00718 |
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data |
Frutalose® chicory oligofructose |
Frutalose® chicory oligofructose contributes to regular bowel function by increasing stool frequency (And three other alternative wordings) |
Q-2020-00631 |
For further information (in English), click on the Link